247 related articles for article (PubMed ID: 30279047)
21. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
[TBL] [Abstract][Full Text] [Related]
22. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
23. White matter hyperintensities relate to executive dysfunction, apathy, but not disinhibition in long-term adult survivors of pediatric cerebellar tumor.
Haller OC; Aleksonis HA; Krishnamurthy LC; King TZ
Neuroimage Clin; 2022; 33():102891. PubMed ID: 34922123
[TBL] [Abstract][Full Text] [Related]
24. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
Chen J; Liu P; Wang Q; Wu L; Zhang X
Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
[TBL] [Abstract][Full Text] [Related]
25. Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury.
Tang Y; Luo D; Rong X; Shi X; Peng Y
PLoS One; 2012; 7(6):e36529. PubMed ID: 22701557
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus.
Hsiung CY; Huang EY; Ting HM; Huang HY
Br J Radiol; 2008 Oct; 81(970):809-14. PubMed ID: 18591201
[TBL] [Abstract][Full Text] [Related]
27. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.
Cho TY; Cheng PW; Young YH
Laryngoscope; 2016 Sep; 126(9):2016-21. PubMed ID: 26864918
[TBL] [Abstract][Full Text] [Related]
28. [Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma: intensity-modulated radiotherapy versus conventional radiotherapy].
Zhang Y; Lin ZA; Pan JJ; Zheng Z; Yang L; Lin SJ; Zheng F
Ai Zheng; 2009 Nov; 28(11):1143-8. PubMed ID: 19895733
[TBL] [Abstract][Full Text] [Related]
29. Cognitive and neuropsychiatric impairment in cerebral radionecrosis patients after radiotherapy of nasopharyngeal carcinoma.
Wu X; Gu M; Zhou G; Xu X; Wu M; Huang H
BMC Neurol; 2014 Jan; 14():10. PubMed ID: 24418214
[TBL] [Abstract][Full Text] [Related]
30. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
31.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
33. [Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy].
Liu Y; Chen M; Zhao C; Lu LX; Han F; Bao Y; Huang SM; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2007 Jan; 26(1):64-7. PubMed ID: 17222370
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
36. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
37. Late sensorial alterations in different radiotherapy techniques for nasopharyngeal cancer.
Riva G; Raimondo L; Ravera M; Moretto F; Boita M; Potenza I; Rampino M; Ricardi U; Garzaro M
Chem Senses; 2015 May; 40(4):285-92. PubMed ID: 25800268
[TBL] [Abstract][Full Text] [Related]
38. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
39. Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.
Pope CN; Montoya JL; Vasquez E; Pérez-Santiago J; Ellis R; McCutchan JA; Jeste DV; Moore DJ; Marquine MJ
J Neurovirol; 2020 Dec; 26(6):888-898. PubMed ID: 32734380
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
